RHEINFELDEN, Switzerland, October, 28th, 2019 – Tillotts Pharma AG ("Tillotts"), part of the Japanese Zeria Group and A. Menarini International Trading (Wuhan) Co. Ltd. ("Menarini"), a member of the Italian A. Menarini Group today announced an agreement for the distribution and marketing of Tillotts Asacol® product range in the People's Republic of China ("China").

Florence, 12th September 2019 - The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas" commented Eric Cornut, Chairman of Menarini.

23 July 2019, Kula Lumpur - Dermatix®, a brand of A.Menarini Singapore Pte.Ltd has just launched its new acne scar care, Dermatix® Acne Scar. Formulating with Niacinamide (Vitamin B3), Alpha Hydroxy Acids (AHAs) and antioxidants, it delivers a gentle exfoliation to repair acne scars for an overall more even skin tone. Created by top derma experts in Europe, it is now available in Malaysia -the Asia Pacific's first country in launching the product.

CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers sales and marketing of CALECIM® products to six of the largest skincare markets in the region: China, Hong Kong, Thailand, Malaysia, Philippines and Indonesia; expanding CALECIM®'s global reach to markets of over 1.7 billion people.